pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens

Keyphrases

• Adoptive Cell Therapy 33%
• Antitumor T Cells 33%
• Cancer Immunotherapy 33%
• Cancer Sequencing 100%
• Checkpoint Blockade 33%
• Checkpoint Therapy 33%
• Clinical Efficacy 33%
• Computational Workflow 33%
• DNA-seq 33%
• Expression Data 33%
• In Silico Methods 100%
• Massively Parallel 33%
• Mutant Peptide 33%
• Mutation Data 33%
• Mutational Load 33%
• Neoantigen 33%
• Parallel Sequencing 33%
• RNA Sequencing (RNA-seq) 33%
• Sequence Analysis 33%
• T Cell Immunity 33%
• Therapy Response 33%
• Tumor Expression 33%
• Tumor mutation Burden 33%
• Tumor Neoantigens 100%
• Tumor-specific 33%

Medicine and Dentistry

• Cancer Immunotherapy 33%
• Cell Therapy 33%
• Cellular Immunity 33%
• In Silico 100%
• Malignant Neoplasm 100%
• Mutational Load 33%
• Neoplasm 100%
• Protein Sequencing 33%
• RNA Sequencing 33%
• Sequence Analysis 33%
• Specific Tumor 33%
• T Cell 33%
• Treatment Response 33%

Biochemistry, Genetics and Molecular Biology

• Cancer Immunotherapy 100%
• Cellular Immunity 100%
• Mutational Load 100%
• Protein Sequencing 100%
• RNA Sequencing 100%
• T Cell 100%